Benzothiazinones (BTZs) are being developed as new antibiotics against the infection caused by Mycobacterium tuberculosis, however, BTZs can undergo an in vivo biotransformation to hydride-Meisenheimer complexes (HMC). Here, the authors show that HMC formation can be modulated by C-6 substitution of BTZ.
- François Keiff
- Freddy A. Bernal
- Florian Kloss
